• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新定义禁水-加压素试验的诊断临界值。

Redefining Diagnostic Cut-Offs for the Indirect Water Deprivation Test.

作者信息

Akkara Yash, Narula Kavita, Lazarus Katharine, Papadopoulou Deborah, Choudhury Sirazum, Martin Niamh, Meeran Karim

机构信息

Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism Digestion and Reproduction, Imperial College London, London, UK.

Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK.

出版信息

Clin Endocrinol (Oxf). 2025 Feb;102(2):149-155. doi: 10.1111/cen.15172. Epub 2024 Dec 5.

DOI:10.1111/cen.15172
PMID:39639680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11694560/
Abstract

OBJECTIVE

An incorrect diagnosis of arginine vasopressin deficiency and resistance (AVP-D and AVP-R) results in the potentially dangerous use of desmopressin in healthy individuals. The water deprivation test is a central diagnostic test in patients with polydipsia polyuria syndrome (PPS). This study aims to determine the effectiveness of the current interpretation of reference ranges.

METHODS

This is a retrospective analysis of 135 patients who underwent a water deprivation test between August 2014 and August 2023. All patient diagnoses were reviewed, and variability and receiver operating characteristic (ROC) curves were determined for serum osmolality, serum sodium and urine osmolality.

RESULTS

Serum sodium demonstrated reduced variability compared with serum osmolality (0.72% vs. 1.16%, respectively, 37.5% reduction; p < 0.001). The standard serum osmolality cut-off value of ≥ 300 mOsm/kg in diagnosing AVP-D, AVP-R, and primary polydipsia (PP) achieved a sensitivity of 76.19% and specificity of 76.92%. A serum sodium cut-off value of ≥ 148 mmol/L demonstrated 100% specificity in excluding PP. This cut-off was used alongside urine osmolality cut-off values of > 630 mOsm/kg (for PP) and < 383 mOsm/kg (for AVP-D/AVP-R). Review of post-desmopressin urine osmolality and clinical monitoring was performed in equivocal diagnostic cases (n = 6), achieving 100% sensitivity and 100% specificity within the study sample.

CONCLUSIONS

This study demonstrates that a serum sodium cut-off of ≥ 148 mmol/L in tandem with urine osmolality yields the best diagnostic accuracy to differentiate between AVP-D, AVP-R, and PP. Serum sodium may be more reliable than serum osmolality in the investigation of patients with PPS, demonstrating lower biological and analytical variability.

摘要

目的

精氨酸血管加压素缺乏和抵抗(AVP-D和AVP-R)的错误诊断会导致在健康个体中潜在危险地使用去氨加压素。禁水试验是多饮多尿综合征(PPS)患者的核心诊断试验。本研究旨在确定当前参考范围解读的有效性。

方法

这是一项对2014年8月至2023年8月期间接受禁水试验的135例患者的回顾性分析。回顾了所有患者的诊断,并确定了血清渗透压、血清钠和尿渗透压的变异性及受试者操作特征(ROC)曲线。

结果

与血清渗透压相比,血清钠的变异性降低(分别为0.72%和1.16%,降低了37.5%;p < 0.001)。在诊断AVP-D、AVP-R和原发性烦渴(PP)时,标准血清渗透压临界值≥300 mOsm/kg的灵敏度为76.19%,特异性为76.92%。血清钠临界值≥148 mmol/L在排除PP方面显示出100%的特异性。该临界值与尿渗透压临界值>630 mOsm/kg(用于PP)和<383 mOsm/kg(用于AVP-D/AVP-R)一起使用。对诊断不明确的病例(n = 6)进行了去氨加压素后尿渗透压回顾和临床监测,在研究样本中实现了100%的灵敏度和100%的特异性。

结论

本研究表明,血清钠临界值≥148 mmol/L与尿渗透压相结合可产生最佳诊断准确性,以区分AVP-D、AVP-R和PP。在PPS患者的调查中,血清钠可能比血清渗透压更可靠,显示出更低的生物学和分析变异性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad63/11694560/902f2e661310/CEN-102-149-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad63/11694560/e5edba864dde/CEN-102-149-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad63/11694560/fbe8986627a0/CEN-102-149-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad63/11694560/cac4fac648b8/CEN-102-149-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad63/11694560/902f2e661310/CEN-102-149-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad63/11694560/e5edba864dde/CEN-102-149-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad63/11694560/fbe8986627a0/CEN-102-149-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad63/11694560/cac4fac648b8/CEN-102-149-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad63/11694560/902f2e661310/CEN-102-149-g002.jpg

相似文献

1
Redefining Diagnostic Cut-Offs for the Indirect Water Deprivation Test.重新定义禁水-加压素试验的诊断临界值。
Clin Endocrinol (Oxf). 2025 Feb;102(2):149-155. doi: 10.1111/cen.15172. Epub 2024 Dec 5.
2
A COMBINED OUTPATIENT AND INPATIENT OVERNIGHT WATER DEPRIVATION TEST IS EFFECTIVE AND SAFE IN DIAGNOSING PATIENTS WITH POLYURIA-POLYDIPSIA SYNDROME.联合门诊和住院夜间禁水试验诊断多尿多饮综合征患者有效且安全。
Endocr Pract. 2018 Nov;24(11):963-972. doi: 10.4158/EP-2018-0238. Epub 2018 Aug 14.
3
Diagnostic Accuracy of Copeptin in the Differential Diagnosis of the Polyuria-polydipsia Syndrome: A Prospective Multicenter Study.copeptin在多尿-多饮综合征鉴别诊断中的诊断准确性:一项前瞻性多中心研究。
J Clin Endocrinol Metab. 2015 Jun;100(6):2268-74. doi: 10.1210/jc.2014-4507. Epub 2015 Mar 13.
4
Copeptin role in polyuria-polydipsia syndrome differential diagnosis and reference range in paediatric age. copeptin 在小儿多尿多饮综合征鉴别诊断和参考范围中的作用。
Clin Endocrinol (Oxf). 2018 Jun;88(6):873-879. doi: 10.1111/cen.13583. Epub 2018 Mar 15.
5
A post-hoc internal validation of arginine-stimulated copeptin cut-offs for diagnosing AVP deficiency (central diabetes insipidus).用于诊断精氨酸加压素缺乏症(中枢性尿崩症)的精氨酸刺激后 copeptin 临界值的事后内部验证。
Pituitary. 2025 Apr 26;28(3):53. doi: 10.1007/s11102-025-01523-2.
6
Diagnostic value of the water deprivation test in the polyuria-polydipsia syndrome.禁水试验在多尿多饮综合征中的诊断价值。
Hormones (Athens). 2017 Oct;16(4):414-422. doi: 10.14310/horm.2002.1762.
7
The diagnostic performance of copeptin in clinical practice: A prospective study. copeptin 在临床实践中的诊断性能:一项前瞻性研究。
Clin Endocrinol (Oxf). 2024 Jul;101(1):23-31. doi: 10.1111/cen.15018. Epub 2024 Jan 30.
8
Simplified and improved fluid deprivation test for diagnosing diabetes insipidus.简化并改进的禁水试验用于诊断尿崩症。
Eur J Endocrinol. 2021 Jan;184(1):123-131. doi: 10.1530/EJE-20-0759.
9
Diagnosis of central diabetes insipidus using a vasopressin radioimmunoassay during hypertonic saline infusion.在高渗盐水输注期间使用血管加压素放射免疫测定诊断中枢性尿崩症。
Endocr J. 2020 Mar 28;67(3):267-274. doi: 10.1507/endocrj.EJ19-0224. Epub 2019 Nov 19.
10
Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome--revisiting the direct and indirect water deprivation tests. copeptin 在多饮多尿综合征鉴别诊断中的作用——重新审视直接和间接禁水试验。
J Clin Endocrinol Metab. 2011 May;96(5):1506-15. doi: 10.1210/jc.2010-2345. Epub 2011 Mar 2.

本文引用的文献

1
Use of copeptin in interpretation of the water deprivation test.应用 copeptin 解读禁水试验。
Endocrinol Diabetes Metab. 2023 May;6(3):e399. doi: 10.1002/edm2.399. Epub 2023 Mar 31.
2
Diagnosis and Management of Central Diabetes Insipidus in Adults.成人中枢性尿崩症的诊断与治疗。
J Clin Endocrinol Metab. 2022 Sep 28;107(10):2701-2715. doi: 10.1210/clinem/dgac381.
3
Diagnosis and differential diagnosis of diabetes insipidus: Update.尿崩症的诊断和鉴别诊断:更新。
Best Pract Res Clin Endocrinol Metab. 2020 Sep;34(5):101398. doi: 10.1016/j.beem.2020.101398. Epub 2020 Feb 28.
4
Diabetes insipidus.尿崩症。
Nat Rev Dis Primers. 2019 Aug 8;5(1):54. doi: 10.1038/s41572-019-0103-2.
5
A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus.基于 copeptin 的尿崩症诊断方法。
N Engl J Med. 2018 Aug 2;379(5):428-439. doi: 10.1056/NEJMoa1803760.
6
Polyuria-polydipsia syndrome: a diagnostic challenge.多尿-烦渴综合征:一项诊断挑战。
Intern Med J. 2018 Mar;48(3):244-253. doi: 10.1111/imj.13627.
7
Stability of serum, plasma and urine osmolality in different storage conditions: Relevance of temperature and centrifugation.血清、血浆和尿液渗透压在不同储存条件下的稳定性:温度和离心的相关性
Clin Biochem. 2017 Sep;50(13-14):772-776. doi: 10.1016/j.clinbiochem.2017.03.019. Epub 2017 Apr 2.
8
Diabetes insipidus: The other diabetes.尿崩症:另一种糖尿病。
Indian J Endocrinol Metab. 2016 Jan-Feb;20(1):9-21. doi: 10.4103/2230-8210.172273.
9
Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects.健康受试者在缺水和水过量状态下,血浆中copeptin(精氨酸加压素的C末端部分)的变化。
J Clin Endocrinol Metab. 2007 Oct;92(10):3973-8. doi: 10.1210/jc.2007-0232. Epub 2007 Jul 17.
10
A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria.血浆血管加压素测量与标准间接试验在多尿鉴别诊断中的比较。
N Engl J Med. 1981 Dec 24;305(26):1539-46. doi: 10.1056/NEJM198112243052601.